Positive reports came almost entirely from the group that discovered the peptide
Bioidentical Hormone Replacement is also a proven option
however, individual response varies considerably based on metabolic, genetic, and lifestyle factors
10, 2024 "Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-F)" Centers for Medicare & Medicaid Services
This combination can also trigger changes in oncogenes like RAS mutations, which encode p21, suppress tumor suppressor genes, and cause DNA damage, ultimately leading to esophageal squamous cell carcinoma (ESCC) [172]